Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose nebulized amikacin pharmacokinetics in ventilator-associated pneumonia
2008-000248-15Phase 2Active
- Sponsor
- Association pour la promotion de la réanimation médicale à Tours
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of amikacin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Association pour la promotion de la réanimation médicale à Tours. Started Jun 2008; status: active.
02
Drugs
amikacin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2008-000248-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000248-15.